Ruth A. Ross

13.3k total citations · 2 hit papers
111 papers, 9.8k citations indexed

About

Ruth A. Ross is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Ruth A. Ross has authored 111 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Pharmacology, 61 papers in Cellular and Molecular Neuroscience and 25 papers in Molecular Biology. Recurrent topics in Ruth A. Ross's work include Cannabis and Cannabinoid Research (90 papers), Neuroscience and Neuropharmacology Research (39 papers) and Neurotransmitter Receptor Influence on Behavior (33 papers). Ruth A. Ross is often cited by papers focused on Cannabis and Cannabinoid Research (90 papers), Neuroscience and Neuropharmacology Research (39 papers) and Neurotransmitter Receptor Influence on Behavior (33 papers). Ruth A. Ross collaborates with scholars based in United Kingdom, Canada and United States. Ruth A. Ross's co-authors include Roger G. Pertwee, Gemma L. Baillie, Adèle Thomas, Raphael Mechoulam, Ken Mackie, Lesley Stevenson, Vincenzo Di Marzo, Raj K. Razdan, Peter J. Greasley and Andrew J. Irving and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Ruth A. Ross

107 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

2010 1.3k citations Roger G. Pertwee, Allyn C. Howlett et al. profile →
Cannabidiol displays unexpectedly high potency as an antagonist of CB₁and CB₂receptor agonistsin vitro

2007 621 citations Ruth A. Ross, Roger G. Pertwee et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruth A. Ross United Kingdom	45	7.9k	4.5k	2.0k	1.5k	1.3k	111	9.8k
Nephi Stella United States	49	8.2k 1.0×	6.0k 1.4×	2.0k 1.0×	2.4k 1.6×	1.0k 0.8×	107	11.6k
Mary E. Abood United States	52	6.7k 0.9×	4.5k 1.0×	2.7k 1.4×	1.1k 0.7×	979 0.8×	130	9.1k
Takayuki Sugiura Japan	51	6.5k 0.8×	3.0k 0.7×	2.8k 1.4×	1.5k 1.0×	1.4k 1.1×	130	10.2k
Filomena Fezza Italy	43	6.1k 0.8×	3.0k 0.7×	1.0k 0.5×	1.2k 0.8×	1.0k 0.8×	80	7.8k
Graeme Griffin United States	21	6.3k 0.8×	3.5k 0.8×	1.5k 0.8×	1.3k 0.8×	870 0.7×	28	8.0k
Zvi Vogel Israel	46	5.6k 0.7×	4.4k 1.0×	3.1k 1.6×	1.2k 0.8×	799 0.6×	106	9.4k
Aviva Breuer Israel	28	7.0k 0.9×	3.5k 0.8×	907 0.5×	1.4k 1.0×	740 0.6×	38	7.9k
Lesley Stevenson United Kingdom	17	5.9k 0.8×	3.3k 0.7×	1.1k 0.6×	1.1k 0.8×	642 0.5×	30	6.7k
Michelle Glass New Zealand	49	6.5k 0.8×	5.0k 1.1×	1.9k 1.0×	1.1k 0.7×	742 0.6×	142	8.9k
Javier Fernández‐Ruíz Spain	73	13.2k 1.7×	9.4k 2.1×	2.1k 1.1×	2.5k 1.7×	862 0.7×	285	16.7k

Countries citing papers authored by Ruth A. Ross

Since Specialization

Citations

This map shows the geographic impact of Ruth A. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth A. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth A. Ross more than expected).

Fields of papers citing papers by Ruth A. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth A. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth A. Ross. The network helps show where Ruth A. Ross may publish in the future.

Co-authorship network of co-authors of Ruth A. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth A. Ross. A scholar is included among the top collaborators of Ruth A. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth A. Ross. Ruth A. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greig, Iain R. & Ruth A. Ross. (2025). Designer cannabinoids could be the key to pain relief without adverse effects. Nature. 640(8057). 45–46.

Mielnik, Catharine A., et al.. (2025). 564. The Bidirectional Effect of 2-AG on Hyperdopaminergic States: Implications for 2-AG Modulation in Dopamine Pathologies. Biological Psychiatry. 97(9). S331–S331. 1 indexed citations

Abood, Mary E., Christian C. Felder, Peter J. Greasley, et al.. (2025). Cannabinoid receptors in GtoPdb v.2025.1. IUPHAR/BPS Guide to Pharmacology CITE. 2025(1).

Mielnik, Catharine A., et al.. (2025). 566. The Modulatory Role of Endocananbinoids in Hyperdopamineric PHENOTYPES: A Novel “AT-RISK” Model of Psychosis. Biological Psychiatry. 97(9). S331–S332. 1 indexed citations

Meyer, Jeffrey H., Kimberly L. Desmond, Ruth A. Ross, et al.. (2025). Fatty acid amide hydrolase in major depressive episodes: A [11C]CURB positron emission tomography study. Neuropsychopharmacology. 50(10). 1536–1543. 1 indexed citations

Murataeva, Natalia, Wenwen Du, Ruth A. Ross, et al.. (2024). CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid Toxicity. Molecules. 29(8). 1881–1881. 2 indexed citations

Abood, Mary E., S P H Alexander, Francis Barth, et al.. (2023). Cannabinoid receptors in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023(1). 3 indexed citations

Mielnik, Catharine A., et al.. (2022). Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of Psychosis. Cannabis and Cannabinoid Research. 9(1). 174–187. 1 indexed citations

Abood, Mary E., S P H Alexander, Francis Barth, et al.. (2019). Cannabinoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019(4). 12 indexed citations

10.

Cowie, Philip, et al.. (2019). Disease‐associated polymorphisms within the conserved ECR1 enhancer differentially regulate the tissue‐specific activity of the cannabinoid‐1 receptor gene promoter; implications for cannabinoid pharmacogenetics. Human Mutation. 41(1). 291–298. 4 indexed citations

11.

Anavi‐Goffer, Sharon, Andrew J. Irving, & Ruth A. Ross. (2016). Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB ₂ receptor agonists: identifying novel GPR55 inhibitors. Journal of Basic and Clinical Physiology and Pharmacology. 27(3). 303–310. 6 indexed citations

12.

Poklis, Justin L., Bogna M. Ignatowska‐Jankowska, Chiara Zanato, et al.. (2015). HPLC-MS-MS Determination of ZCZ-011, A Novel Pharmacological Tool for Investigation of the Cannabinoid Receptor in Mouse Brain Using Clean Screen FASt Column Extraction. Journal of Analytical Toxicology. 39(5). 353–358. 5 indexed citations

13.

Sylantyev, Sergiy, Thomas P. Jensen, Ruth A. Ross, & Dmitri A. Rusakov. (2013). Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses. Proceedings of the National Academy of Sciences. 110(13). 5193–5198. 164 indexed citations

14.

Romero‐Zerbo, Silvana‐Yanina, Alex Rafacho, Juan Suárez, et al.. (2011). A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. Journal of Endocrinology. 211(2). 177–185. 98 indexed citations

15.

Moreno‐Navarrete, José María, Victoria Catalán, Lauren S. Whyte, et al.. (2011). Thel-α-Lysophosphatidylinositol/GPR55System and Its Potential Role in Human Obesity. Diabetes. 61(2). 281–291. 133 indexed citations

16.

Ross, Ruth A.. (2003). Anandamide and vanilloid TRPV1 receptors. British Journal of Pharmacology. 140(5). 790–801. 474 indexed citations

17.

Ross, Ruth A., Angela A. Coutts, Shona M. McFarlane, et al.. (2001). Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology. 40(2). 221–232. 147 indexed citations

18.

Ross, Ruth A., et al.. (2000). Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide. European Journal of Pharmacology. 401(2). 121–130. 97 indexed citations

19.

Ross, Ruth A., et al.. (1999). Agonist‐inverse agonist characterization at CB₁ and CB₂ cannabinoid receptors of L759633, L759656 and AM630. British Journal of Pharmacology. 126(3). 665–672. 347 indexed citations

20.

Ross, Ruth A., et al.. (1960). FAMILIAL ECLAMPSIA. BJOG An International Journal of Obstetrics & Gynaecology. 67(6). 971–974. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact